Psychosomatic medicine is a specialized field of medicine that focuses on the interaction between the mind and body in the context of health and illness. It explores how psychological factors, such as stress, emotions, beliefs, and personality traits, can influence physical health outcomes and vice versa. The field emphasizes the interconnectedness of mental, emotional, and physical well-being, recognizing that psychological factors can play a significant role in the onset, progression, and management of various medical conditions.
Practitioners of psychosomatic medicine employ a biopsychosocial approach to patient care, integrating biological, psychological, and social perspectives into the assessment and treatment of individuals with complex medical and psychiatric conditions. They collaborate closely with other healthcare professionals, including physicians, psychologists, social workers, and nurses, to provide comprehensive care that addresses both the physical and psychological aspects of illness. Treatment modalities may include psychotherapy, stress management techniques, lifestyle modifications, and medication management, tailored to the specific needs and preferences of each patient. By addressing the interplay between mind and body, psychosomatic medicine aims to optimize patient outcomes, enhance quality of life, and promote holistic well-being across the lifespan.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States